Experimental treatment of oestrogen receptor (ER) positive breast cancer with tamoxifen and brivanib alaninate, a VEGFR-2/FGFR-1 kinase inhibitor: a potential clinical application of angiogenesis inhibitors (Q34082909)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Experimental treatment of oestrogen receptor (ER) positive breast cancer with tamoxifen and brivanib alaninate, a VEGFR-2/FGFR-1 kinase inhibitor: a potential clinical application of angiogenesis inhibitors |
scientific article |
Statements
1 reference
Experimental treatment of oestrogen receptor (ER) positive breast cancer with tamoxifen and brivanib alaninate, a VEGFR-2/FGFR-1 kinase inhibitor: a potential clinical application of angiogenesis inhibitors (English)
1 reference
V Craig Jordan
1 reference
Roshani R Patel
1 reference
Surojeet Sengupta
1 reference
Helen R Kim
1 reference
Andres J Klein-Szanto
1 reference
Jennifer R Pyle
1 reference
Fang Zhu
1 reference
Tianyu Li
1 reference
Eric A Ross
1 reference
Salewa Oseni
1 reference
Joseph Fargnoli
1 reference
18 March 2010
1 reference
1 reference
46
1 reference
1537-1553
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference